PMC:7079563 / 11319-11467 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"334","span":{"begin":29,"end":38},"obj":"Species"},{"id":"335","span":{"begin":39,"end":47},"obj":"Species"},{"id":"336","span":{"begin":122,"end":130},"obj":"Species"},{"id":"337","span":{"begin":134,"end":142},"obj":"Species"},{"id":"347","span":{"begin":98,"end":106},"obj":"Disease"}],"attributes":[{"id":"A334","pred":"tao:has_database_id","subj":"334","obj":"Tax:2697049"},{"id":"A335","pred":"tao:has_database_id","subj":"335","obj":"Tax:9606"},{"id":"A336","pred":"tao:has_database_id","subj":"336","obj":"Tax:1335626"},{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"Tax:694009"},{"id":"A347","pred":"tao:has_database_id","subj":"347","obj":"MESH:D003967"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In addition, about 20–25% of 2019-nCoV patients experience intestinal symptoms and signs (such as diarrhea), similarly to MERS-CoV or SARS-CoV [17]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":59,"end":69},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma7199"}],"text":"In addition, about 20–25% of 2019-nCoV patients experience intestinal symptoms and signs (such as diarrhea), similarly to MERS-CoV or SARS-CoV [17]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T47","span":{"begin":98,"end":106},"obj":"Disease"},{"id":"T48","span":{"begin":134,"end":142},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"In addition, about 20–25% of 2019-nCoV patients experience intestinal symptoms and signs (such as diarrhea), similarly to MERS-CoV or SARS-CoV [17]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T61","span":{"begin":59,"end":69},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T62","span":{"begin":59,"end":69},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"}],"text":"In addition, about 20–25% of 2019-nCoV patients experience intestinal symptoms and signs (such as diarrhea), similarly to MERS-CoV or SARS-CoV [17]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T87","span":{"begin":0,"end":148},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, about 20–25% of 2019-nCoV patients experience intestinal symptoms and signs (such as diarrhea), similarly to MERS-CoV or SARS-CoV [17]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":98,"end":106},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0002014"}],"text":"In addition, about 20–25% of 2019-nCoV patients experience intestinal symptoms and signs (such as diarrhea), similarly to MERS-CoV or SARS-CoV [17]."}

{"project":"2_test","denotations":[{"id":"32087334-31986264-69695003","span":{"begin":144,"end":146},"obj":"31986264"}],"text":"In addition, about 20–25% of 2019-nCoV patients experience intestinal symptoms and signs (such as diarrhea), similarly to MERS-CoV or SARS-CoV [17]."}